KE3064A - Process for the preparation of cephadroxil - Google Patents

Process for the preparation of cephadroxil

Info

Publication number
KE3064A
KE3064A KE3064A KE306480A KE3064A KE 3064 A KE3064 A KE 3064A KE 3064 A KE3064 A KE 3064A KE 306480 A KE306480 A KE 306480A KE 3064 A KE3064 A KE 3064A
Authority
KE
Kenya
Prior art keywords
cephadroxil
preparation
Prior art date
Application number
KE3064A
Other languages
English (en)
Inventor
A Weber
D Bouzard
J Stemer
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10087928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KE3064(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of KE3064A publication Critical patent/KE3064A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KE3064A 1976-04-27 1980-07-09 Process for the preparation of cephadroxil KE3064A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17028/76A GB1532682A (en) 1976-04-27 1976-04-27 Process for the preparation of cephadroxil

Publications (1)

Publication Number Publication Date
KE3064A true KE3064A (en) 1980-07-25

Family

ID=10087928

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3064A KE3064A (en) 1976-04-27 1980-07-09 Process for the preparation of cephadroxil

Country Status (26)

Country Link
US (3) US4234721A (fr)
JP (2) JPS6022717B2 (fr)
AT (1) AT350183B (fr)
AU (1) AU510338B2 (fr)
BE (1) BE853974A (fr)
CA (1) CA1115268A (fr)
CH (1) CH632270A5 (fr)
CY (1) CY1066A (fr)
DE (1) DE2718741C2 (fr)
DK (1) DK157026C (fr)
ES (1) ES458241A1 (fr)
FI (1) FI67704C (fr)
FR (2) FR2349589A1 (fr)
GB (1) GB1532682A (fr)
GR (1) GR72788B (fr)
HK (1) HK39780A (fr)
IE (1) IE44872B1 (fr)
IT (1) IT8049917A0 (fr)
KE (1) KE3064A (fr)
LU (1) LU77202A1 (fr)
MY (1) MY8100135A (fr)
NL (1) NL7704618A (fr)
PH (2) PH16581A (fr)
SE (1) SE437521B (fr)
YU (2) YU39801B (fr)
ZA (1) ZA772485B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR820001564B1 (ko) * 1981-05-09 1982-09-02 동신제약 주식회사 새로운 실릴화제를 이용한 세팔로스포린 유도체의 제조방법
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60169486A (ja) * 1984-02-10 1985-09-02 Yamanouchi Pharmaceut Co Ltd ７−アミノ−３−置換メチル−３−セフエム−４−カルボン酸およびその低級アルキルシリル誘導体の製造法
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
US4904776A (en) * 1987-04-24 1990-02-27 Rifar S.R.L. Method for producing crystalline cefadroxil hemihydrate
US4962195A (en) * 1987-04-24 1990-10-09 Rifar S.R.L. Solvate of cefadroxyl
US5023331A (en) * 1987-04-24 1991-06-11 Rifar S.R.L. Cefadroxil solvates
US4898938A (en) * 1987-08-03 1990-02-06 Rifar S.R.L. Method for preparing crystalline cefadroxil monohydrate
IT1233863B (it) * 1988-02-24 1992-04-21 Opos Biochimica Srl Procedimento per la preparazione dell'acido 7-(d(-)-alfa-amino-alfa- (p-idrossifenil)acetamido)-3-metil-3-cefem-4-carbossilico monoidrato
US5034522A (en) * 1988-08-02 1991-07-23 Biocraft Laboratories, Inc. Method for the production of 3-methyl cephem derivatives
WO1991000865A1 (fr) * 1989-07-10 1991-01-24 Gema S.A. Nouvelle forme de cephradine stable, procede de production de celle-ci, et produits intermediaires utilises
US5142043A (en) * 1990-05-10 1992-08-25 Biocraft Laboratories, Inc. Process for preparing cephalexin monohydrate
ES2157199T3 (es) 1991-03-08 2001-08-16 Biochemie Gmbh Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento.
US6248881B1 (en) 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
AT396106B (de) * 1991-03-08 1993-06-25 Biochemie Gmbh Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen
SK283674B6 (sk) * 1993-03-12 2003-11-04 Pharmacia & Upjohn Company Kryštalická voľná kyselina ceftiofuru a spôsob jej prípravy a farmaceutická kompozícia, ktorá ju obsahuje
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
CA2184598C (fr) 1994-04-15 2005-05-03 Jeffrey L. Havens Nouvelles formes cristallines de 1-[5-methanesulfonamidoindolyle-2-carbonyle]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
IT1289955B1 (it) * 1997-02-21 1998-10-19 Solchem Italiana Spa Acyclovir sale sodico biidrato e sua preparazione
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
WO2001004126A1 (fr) * 1999-07-14 2001-01-18 Ranbaxy Laboratories Limited Procede de preparation de semi-hydrate cefadroxil cristallin a partir d'un produit de solvatation cefadroxil dimethyl formamide
IN190389B (fr) 1999-07-14 2003-07-26 Ranbaxy Lab Ltd
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US20040077849A1 (en) * 2002-10-16 2004-04-22 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefadroxil
EP1562900A4 (fr) * 2002-11-08 2006-07-12 Dov Pharmaceutical Inc Polymorphes du chlorhydrate de bicifadine
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US7230097B2 (en) 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
BRPI0613943B1 (pt) 2005-07-27 2021-06-22 Otsuka America Pharmaceutical, Inc Composto, composição farmacêutica o compreendendo, usos de um composto e de uma composição farmacêutica, bem como composição neurobiologicamente ativa
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
EP2024374A1 (fr) * 2006-05-19 2009-02-18 DSMIP Assets B.V. Procédé de cristallisation du céfadroxil
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US20080269348A1 (en) * 2006-11-07 2008-10-30 Phil Skolnick Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
CA2676984C (fr) 2007-02-01 2015-03-17 Resverlogix Corp. Composes destines a la prevention et au traitement de maladies cardiovasculaires
US20090069374A1 (en) * 2007-06-06 2009-03-12 Phil Skolnick Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
CN102408438B (zh) * 2010-09-26 2015-01-07 石药集团中奇制药技术（石家庄）有限公司 一种头孢丙烯一水合物的制备方法
CN102134250B (zh) * 2011-01-19 2013-03-13 天津大学 一种头孢羟氨苄单水合物的结晶方法及结晶
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29164A (en) * 1860-07-17 Improvement in fish-oils
USRE29164E (en) 1967-09-05 1977-03-29 Bristol-Myers Company 7-Amino-cephalosporanic and decephalosporanic acid derivatives
US3489750A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
US3694437A (en) * 1970-08-19 1972-09-26 Lilly Co Eli Process for preparing cephalosporin compounds
US3781282A (en) * 1971-01-20 1973-12-25 W Garbrecht Cephalosporin process and product
JPS5318515B2 (fr) 1971-12-17 1978-06-15
DE2163514A1 (de) * 1971-12-21 1973-07-05 Toyama Chemical Co Ltd Verfahren zur herstellung von cephalosporinen
FR2166316A1 (en) * 1972-01-07 1973-08-17 Toyama Chemical Co Ltd 7-acylcephalosporins - prepd via a silylated inter
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
DE2354427A1 (de) 1972-11-02 1974-05-16 Lorenzini Sas Inst Biochim Verfahren zur herstellung von 7-(dalpha-aminophenylacetamido)-3-desacetoxycephalosporansaeure
GB1472746A (en) * 1973-07-05 1977-05-04 Glaxo Lab Ltd Cephalosporin compounds
US4091215A (en) * 1974-06-05 1978-05-23 Bristol-Myers Company 7-D-α-Amino-.alpha.-(p-acetoxyphenyl)acetamido-3-methyl-3-cephem-4-carboxylic acid
GB1476981A (en) 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
AU2550077A (en) * 1976-06-14 1978-11-30 Merck Patent Gmbh Penicillins and cephalosporins
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
NL162387C (nl) * 1977-09-06 1980-05-16 Gist Brocades Nv Werkwijze voor het bereiden van 6-(d-alpha-amino-p- -hydroxyfenylacetamido)penicillanzuur.
IT1126544B (it) * 1979-12-07 1986-05-21 Dobfar Spa Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico

Also Published As

Publication number Publication date
IT8049917A0 (it) 1980-10-16
SE7704739L (sv) 1977-12-01
GB1532682A (en) 1978-11-22
GR72788B (fr) 1983-12-05
US4234721A (en) 1980-11-18
YU137982A (en) 1983-04-30
CY1066A (en) 1980-10-24
DK183277A (da) 1977-10-28
JPS60185718A (ja) 1985-09-21
FR2365570A1 (fr) 1978-04-21
DK157026B (da) 1989-10-30
US4504657A (en) 1985-03-12
ES458241A1 (es) 1978-11-01
LU77202A1 (fr) 1977-11-22
BE853974A (fr) 1977-10-26
SE437521B (sv) 1985-03-04
CH632270A5 (de) 1982-09-30
FI67704C (fi) 1985-05-10
YU39801B (en) 1985-04-30
NL7704618A (nl) 1977-10-31
DK157026C (da) 1990-04-02
HK39780A (en) 1980-08-08
USRE31730E (en) 1984-11-13
AU2460777A (en) 1978-11-02
IE44872B1 (en) 1982-04-21
IE44872L (en) 1977-10-27
FR2349589B1 (fr) 1981-11-20
JPS52142091A (en) 1977-11-26
FR2365570B1 (fr) 1980-06-06
MY8100135A (en) 1981-12-31
YU43081B (en) 1989-02-28
ZA772485B (en) 1978-03-29
FR2349589A1 (fr) 1977-11-25
YU108677A (en) 1982-10-31
FI67704B (fi) 1985-01-31
JPH0246009B2 (fr) 1990-10-12
DE2718741C2 (de) 1985-03-21
PH16581A (en) 1983-11-22
JPS6022717B2 (ja) 1985-06-03
AT350183B (de) 1979-05-10
PH17254A (en) 1984-07-03
CA1115268A (fr) 1981-12-29
DE2718741A1 (de) 1977-11-17
AU510338B2 (en) 1980-06-19
FI771339A (fr) 1977-10-28
ATA296277A (de) 1978-10-15

Similar Documents

Publication Publication Date Title
MY8100135A (en) Process for the preparation of cephadroxil
GB1519579A (en) Process for the preparation of mononitro-aromatic compounds
IL52749A0 (en) Process for the preparation of m-phenoxybenzaldehyde
GB1523529A (en) Process for the preparation of tetrazole - 5 - carboxamides
CH608498A5 (en) Process for the preparation of novel 5-methylisoxazole- 4-carboxamides
MY8100267A (en) Process for the preparation of gamma-pyrones
GB1542187A (en) Process for the preparation of organopolysiloxanes
GB1534213A (en) Process for the preparation of basically-substituted phenyl-acetonitriles
HK13083A (en) Process for the preparation of novel benzopyrane derivatives
GB1552402A (en) Process for the preparation of 3-deoxyanthocyanidins
CH609341A5 (en) Process for the preparation of 5-methylisoxazole- 4-carboxanilides
GB1549547A (en) Process for the preparation of 4-phenoxy-phenols
GB1555111A (en) Process for the preparation of substituted chloropyramidines
GB1521436A (en) Process for the preparation of halogeno-acetals from enoxysilanes
PT67309A (en) Process for the preparation of an orthoaminoacetophenone
PT66862B (en) Process for the preparation of cyanoprostaglandins
GB1519931A (en) Process for the preparation of ethyl aminocyanoacetate
PT66654B (en) Process for the preparation of synthetic aminoglicosides
ZA773011B (en) Process for the preparation of 2-aryliminothiazoline solutions
PT66889B (en) Process for the preparation of derivatives of the d-threo-1-phenyl
ATA388379A (de) Katalysator zur herstellung olefinisch ungesaettigter carbonsaeuren
IL51271A (en) Process for the preparation of 0-dialkyl-aminomethylphenols
ZA767468B (en) Process for the preparation of 2-aminoindante derivatives
CS180986B1 (en) Process for the preparation of dimethylterphtalate
GB1554410A (en) Process for the preparation of 2-alkylglycerols